Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients. - Wikidata - wikimedia - TriplyDB

Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients.

Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients.

http://www.wikidata.org/entity/Q51949738

about

Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer Heterozygote advantage of methylenetetrahydrofolate reductase polymorphisms on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy.Transcription factors related to epithelial mesenchymal transition in tumor center and margin in invasive lung adenocarcinoma.Epidemiology of lung cancer prognosis: quantity and quality of life.Expression of Cystatin SN significantly correlates with recurrence, metastasis, and survival duration in surgically resected non-small cell lung cancer patients.Cardamonin Suppresses TGF-β1-Induced Epithelial Mesenchymal Transition via Restoring Protein Phosphatase 2A Expression Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression.Refining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools.A Prognostic Model to Predict Mortality among Non-Small-Cell Lung Cancer Patients in the U.S. Military Health System Prediction and prognostic factors of post-recurrence survival in recurred patients with early-stage NSCLC who underwent complete resection.Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy.The relationship between the preoperative plasma level of HIF-1α and clinic pathological features, prognosis in non-small cell lung cancer.Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma.Isolated brain metastasis as a late recurrence of completely resected non-small cell lung cancer.Topoisomerase I expression is associated with prognosis in postoperative non-small cell lung cancer patients Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status.Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma.Prognosis of recurrent non-small cell lung cancer following complete resection.Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer.Survival outcomes for oligometastasis in resected non-small cell lung cancer.Survival significance of epidermal growth factor receptor tyrosine kinase inhibitors and current staging system for survival after recurrence in patients with completely resected lung adenocarcinoma.Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer.Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy.Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer.Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.Impact of the oncogenic status on the mode of recurrence in resected non-small cell lung cancer.Prognostic Factors for Post Recurrence Survival in Resected Pathological Stage I Non-small Cell Lung Cancer.Current outcomes of postrecurrence survival in patients after resection of non-small cell lung cancer.

P2860

Q27011293-39EE1576-294E-46F7-8D5F-8BF38168470E Q29248373-7441E5A0-181F-4E58-9744-A25656AA59DB Q33416949-025D3386-096B-41FF-B298-6AE761DEA474 Q34029138-F83B22FC-95AB-42E1-BE71-C098E86765B2 Q34135295-37BF7766-EC2D-4DF6-999B-059E2884CB80 Q35046021-16324A72-0805-4A74-BAA0-05F823D22393 Q35161277-7ACC479F-CEB4-491C-A369-D69B40F9EE9D Q35892165-FE4AF36C-156D-48D8-BDA9-26F75F79F42A Q36258014-B6D3DBC8-5FE7-4B41-938D-023CFE29E6D3 Q36414611-FD7548E3-F5CA-41A4-9A73-1317C76D6B1F Q36540289-592B6FE4-C09E-421F-AE29-5DD24D852021 Q36543892-B828DC6D-286B-4C85-A3C2-4286B2C510AE Q36555113-90A84126-5214-4AFB-AA45-ED70A285A089 Q36558386-A94A0411-6BA7-4564-9E11-553FED39BA71 Q36898402-63886849-40C0-4054-A26B-09ED6EF93522 Q37002744-273665B7-6080-4721-8BDE-5A1F00655104 Q37060409-A9FACC0A-B503-4546-86F9-10B9C1FFD148 Q37567804-F27043E4-180B-460D-ADE1-3E7120675F7C Q37597299-E4965F14-0819-4D46-8655-3E5E749FE12C Q37652622-D018FF39-656A-4DB7-82D0-50A1E1CAE3FE Q37701727-03B1DDD2-C4FD-411C-9AB2-A21BD65AFA93 Q38067307-E822292D-9797-438C-AB61-F8D4A261B88E Q40700961-16C67CAB-B9B7-4EFF-A5D7-C48788AADA83 Q41522621-27D045E2-1876-4068-90EE-126A7BF69896 Q41673451-F152A862-25E2-45A9-8795-9398E045E50F Q47099923-4617E01F-160D-4048-A92C-574E2BB588C8 Q47353436-8EDDAE00-75DA-4243-8D84-CB1BF9BF1787 Q47770661-A3FEB5BD-73FA-4BBF-9A74-4AAA15F51D5C Q47974616-32F5FFCE-0958-44F0-9A3D-4640704F69FE Q48627805-34A2CBDF-E1EB-4830-B8F3-F97319EFB128 Q49707854-20140446-4D35-447B-8983-DDE440371885 Q52715754-1BEF0A7D-5955-4C3C-947F-1459A1A807E7

P2860

Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients.

http://www.wikidata.org/entity/Q51949738

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Predicting postrecurrence surv ...... all-cell lung cancer patients.

@en

Predicting postrecurrence surv ...... all-cell lung cancer patients.

@nl

type

label

Predicting postrecurrence surv ...... all-cell lung cancer patients.

@en

Predicting postrecurrence surv ...... all-cell lung cancer patients.

@nl

prefLabel

Predicting postrecurrence surv ...... all-cell lung cancer patients.

@en

Predicting postrecurrence surv ...... all-cell lung cancer patients.

@nl

P1433

Q51949738-E4C3E8DC-64EE-4B20-B6B2-9386AA4B7995

P1476

Q51949738-930492D3-A2B1-4F85-B2F3-E7B6BE0822FD

P2093

Q51949738-2F282019-D6BC-46BC-8BA1-83E62E571AB9

Q51949738-45B5FA0F-FCF3-431F-A85F-8A2EA82113FA

Q51949738-4ED4EB57-5EDD-4A04-9BE5-B00D83239DFC

Q51949738-4F4AF4F0-CF4B-4999-B942-A2D954BBD199

Q51949738-51171709-085A-47C9-9CDF-73CEAF4BD162

Q51949738-65C03BB4-1365-4C26-B825-19F962B7ED21

Q51949738-AE56878B-A5A9-4AD3-917C-A54DB95ACE0E

Q51949738-C5D707EA-BD06-480F-AC87-CA7C2DA671E9

Q51949738-D6267DD6-8640-4E68-966F-78CB3540D00F

P304

Q51949738-6EDBDDAA-4AB4-427C-BB27-734662034EE2

P31

Q51949738-82A13F51-0EF4-43D9-9F6B-D1BF88ADC962

P356

Q51949738-66866F08-AE86-4279-B4EB-1161EC3E8790

P407

Q51949738-E9FF5DFF-1421-40BE-8A95-88B7B8A87E10

P433

Q51949738-B93265EE-4330-4860-B47E-59366AB4007D

P478

Q51949738-62228E18-B36C-4D7C-8591-D75D7589D1F9

P577

Q51949738-15E7DC7B-80B7-4348-9AA7-524C25B61B33

P5875

Q51949738-012F24D5-B2EE-4B0E-AABE-989D720ADCAD

P698

Q51949738-BF3CB7A0-0C51-424E-B520-7BCD58755122

P356

J.ATHORACSUR.2005.09.020

P1433

The Annals of Thoracic Surgery

P1476

Predicting postrecurrence surv ...... all-cell lung cancer patients.

@en

P2093

Brent A Williams

http://www.w3.org/2001/XMLSchema#string

Chiaki Endo

http://www.w3.org/2001/XMLSchema#string

Claude Deschamps

http://www.w3.org/2001/XMLSchema#string

Francis C Nichols

http://www.w3.org/2001/XMLSchema#string

Hiroshi Sugimura

http://www.w3.org/2001/XMLSchema#string

Mark S Allen

http://www.w3.org/2001/XMLSchema#string

Peter C Pairolero

http://www.w3.org/2001/XMLSchema#string

Ping Yang

http://www.w3.org/2001/XMLSchema#string

Stephen D Cassivi

http://www.w3.org/2001/XMLSchema#string

P304

1021-1027

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ATHORACSUR.2005.09.020

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7287930

http://www.w3.org/2001/XMLSchema#string

P698

16488713

http://www.w3.org/2001/XMLSchema#string